Although not statistically significant, the activity of at least 14 other Ser/Thr kinases (e.g. AMPKα1, CaMK2α and PKCε) was markedly reduced in ET (s < −0.30). The gene discussed is PRKAA1; the disease is essential thrombocythemia.